Description
Research Peptide Blend≥99% HPLC StandardShips from Canada
Overview
KLOW is a research blend co-lyophilizing four peptides in a single vial: BPC-157, GHK-Cu (copper tripeptide-1), TB-500 (a thymosin β-4 fragment), and KPV (the C-terminal tripeptide of α-MSH). It is intended for combined-exposure studies.
It extends the GLOW combination with KPV, adding an anti-inflammatory component to the tissue-repair and matrix-synthesis mechanisms of the other three. No published study evaluates this specific blend; the references below concern the individual components. It is offered strictly as a research material, and the studies cited describe preclinical findings only.
Mechanisms of interest in research
BPC-157: cytoprotection and angiogenesis
Studied for effects on blood-vessel formation and cell survival via VEGFR2 and nitric-oxide signalling.
GHK-Cu: extracellular-matrix synthesis
A copper-binding tripeptide studied for stimulating collagen, elastin and glycosaminoglycan synthesis.
TB-500: actin regulation and cell migration
Carries the actin-binding motif of thymosin β-4 and is studied for promoting cell migration in wound repair.
KPV: anti-inflammatory signalling
The C-terminal tripeptide of α-MSH, studied for anti-inflammatory effects — including modulation of NF-κB — that appear partly independent of melanocortin receptors.
Specifications
Selected Research
The following peer-reviewed studies are provided for scientific context on this compound’s research background. They describe preclinical and in-vitro findings only and are not claims about this product.
On BPC-157:
In cultured tendon explants and fibroblasts, BPC-157 increased fibroblast outgrowth and migration via the FAK–paxillin pathway.
Chang CH, et al. J Appl Physiol. PMID: 21030672
On GHK-Cu:
A review reports that GHK stimulates blood-vessel and nerve outgrowth and increases extracellular-matrix synthesis across tissues.
Pickart L, et al. Int J Mol Sci. PMID: 29986520
On TB-500 (thymosin β-4):
In animal-model studies, thymosin β-4 promoted cell migration, blood-vessel formation and cell survival while reducing inflammatory mediators.
Philp D, et al. Ann N Y Acad Sci. PMID: 20536453
On KPV:
KPV showed significant anti-inflammatory effects in two murine models of colitis that appeared at least partly independent of MC1R signalling.
Kannengiesser K, et al. Inflamm Bowel Dis. PMID: 18092346
This product is intended exclusively for in-vitro laboratory research. It is not a drug, food, dietary supplement, or cosmetic, and it is not intended for human or veterinary diagnostic, therapeutic, or recreational use.
